Qualifications - Essential
- PhD or equivalent practical experience in a technical field.
- A proven track record of developing and applying deep learning methods, including experience with modern architectures such as transformers, state-space models, graph neural networks or diffusion-based generative models.
- Proficiency with modern ML frameworks (e.g., PyTorch, JAX, or TensorFlow) and core scientific computing libraries (e.g., NumPy, SciPy, Pandas).
- A genuine enthusiasm for applying cutting-edge ML research to real-world biological problems and a bias towards action.
Qualifications - Nice to have
- Prior experience with ML applied to problems in biology or chemistry.
- Familiarity with multimodal modeling, contrastive learning or self-supervised learning.
- Experience with large scale distributed ML techniques (e.g., FSDP, TP, dMoE, flash attention)
Key Responsibilities
- Develop and apply machine learning techniques towards building multimodal foundation models that bridge the chemical and biological domains, i.e.: integrate models of chemical structure, target protein sequence and whole transcriptome scRNAseq.
- Stay at the forefront of ML and computational biology research and rapidly adopt state-of-the-art techniques to our problems and datasets.
- Collaborate with our team of biologists and engineers in cross-functional pods to test novel ML-driven hypotheses.
Benefits
- Unlimited Paid Time Off (PTO).
- Monthly Lunch budget.
- One-time Office set up budget.
- US Employees: HMO Kaiser Platinum and PPO Anthem Gold medical as well as vision and dental plans for both the employee and dependents.
Top Skills
What We Do
Tahoe Therapeutics (formerly Vevo Therapeutics) is a biotechnology company using its in vivo drug discovery platform and next generation AI models to uncover better drugs for more patients. The company’s Mosaic platform is the first to make in vivo data generation scalable, with single-cell precision, to capture in vivo context of disease at the first step of drug discovery and to better represent patient diversity in drug response over current in vitro assays. Tahoe is using Mosaic to build the world’s largest in vivo atlas of how drugs interact with patient cells and training AI models on its data to find novel targets and drugs undetectable by other technologies.
Located in South San Francisco, CA, Tahoe was founded by a team of inventors and thought leaders who have discovered drugs for “undruggable” targets and invented novel methods in genomics, computational biology, and chemistry. Learn more at www.tahoebio.ai.









